LC-MS identifies oncogene Rab33B in ischemic brain tissue
Up-regulation of the oncogene Rab33B is detected in ischemic brain tissue using LC-MS

HPLC, UHPLC

LC-MS identifies oncogene Rab33B in ischemic brain tissue

26 Nov, 2010

Published over 15 years ago. See the latest and most current information on HPLC, UHPLC.

Research conducted using liquid chromatography-mass spectrometry (LC-MS) has detected higher levels of the oncogene Rab33B in brain tissue following an ischemic cerebral event.

Ischemia occurs when oxygen is unable to reach the tissue in the brain and is the most common cause of stroke.

Typically, it is caused by the blockage of a vessel elsewhere in the body, unlike haemorrhagic stroke which occurs when weakened vessels within the brain itself bleed into the tissue.

A study published in Experimental & Translational Stroke Medicine reports the findings of LC-MS research into the after-effects of ischemic attack.

Specifically, the scientists focused on levels of Rab33B, a known oncogene which, if expressed to a significantly high degree, can be associated with the formation of tumours.

They found a time-dependent link between ischemia in the brain and the number of cells found to be positive for content of Rab33B, with a general up-regulation of the oncogene throughout the ischemic striatum.

Latest News

Explore Our Other Sites

Labmate Online
Mayo Clinic and Thermo Fisher Scientific launch Precure LLC to identify signs of disease before their symptoms appear
Explore more Arrow
Envirotech Online
Connected safety technology company announces CEO appointment and leadership transition
Explore more Arrow
Pollution Solutions Online
Smarter wastewater management helps futureproof distillery operations and protect local watercourses
Explore more Arrow
Petro Online
Improving repeatability in diesel fuel lubricity testing
Explore more Arrow